[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65251]], camposKey:1661-6596 2021-01-01 Cell therapy for colorectal cancer: The promise of Chimeric Antigen Receptor (CAR)-T Cells117810, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58838]], camposKey:0041-1337 2021-01-01 Treatment of Degenerative Disc Disease with Allogeneic Mesenchymal Stem Cells: Long-term Follow-up Results2527, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41609]], camposKey:1931-5244 2019-01-01 A proof-of-concept clinical trial using mesenchymal stem cells for the treatment of corneal epithelial stem cell deficiency1840, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55852]], camposKey:2056-3418 2019-01-01 An elastin-like recombinamer-based bioactive hydrogel embedded with mesenchymal stromal cells as an injectable scaffold for osteochondral repair335347, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52142]], camposKey:1749-799X 2019-01-01 Autologous bone marrow expanded mesenchymal stem cells in patellar tendinopathy: protocol for a phase I/II, single-centre, randomized with active control PRP, double-blinded clinical trial00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55004]], camposKey:1043-0342 2019-01-01 New gene-editing strategy for allogeneic NKG2D-CAR T cell production00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38302]], camposKey:1010-5182 2018-01-01 Repair of maxillary cystic bone defects with mesenchymal stem cells seeded on a cross-linked serum scaffold222229, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47847]], camposKey:0961-2033 2018-01-01 Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis21612165, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=87536]], camposKey:2373-8731 2017-09-01 Influence of HLA Matching on the Efficacy of Allogeneic Mesenchymal Stromal Cell Therapies for Osteoarthritis and Degenerative Disc Disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47865]], camposKey:0146-0404 2017-01-01 A Randomized Controlled Trial of Cultivated Limbal Epithelial Cells Compared to Mesenchymal Stem Cells for the Treatment of Corneal Failure due to Limbal Stem Cell Deficiency00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54399]], camposKey:2530-643X 2017-01-01 ¡AY, Teodora!600, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47039]], camposKey:2373-8731 2017-01-01 Influence of HLA Matching on the Efficacy of Allogeneic Mesenchymal Stromal Cell Therapies for Osteoarthritis and Degenerative Disc Disease2050, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38304]], camposKey:0041-1337 2017-01-01 Intervertebral Disc Repair by Allogeneic Mesenchymal Bone Marrow Cells: A Randomized Controlled Trial19451951, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49997]], camposKey:2296-4185 2016-01-01 Repair of rotator cuff injury in rabbit animal model by in situ implantation of an injectable elastin-like recombinamer and allogeneic mesenchymal stem cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3546]], camposKey:2314-6133 2015-01-01 Stem Cell Therapy for Corneal Epithelium Regeneration following Good Manufacturing and Clinical Procedures00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38310]], camposKey:0041-1337 2015-01-01 Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: A randomized controlled trial16811690, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38311]], camposKey:0041-1337 2014-01-01 Treatment of knee osteoarthritis with autologous mesenchymal stem cells: Two-year follow-up results00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38315]], camposKey:0041-1337 2013-01-01 Treatment of knee osteoarthritis with autologous mesenchymal stem cells: A pilot study15351541, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38318]], camposKey:0065-2598 2012-01-01 Cell and tissue therapy in regenerative medicine89102, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9764]], camposKey:1746-0751 2012-01-01 Generation of inner ear sensory cells from bone marrow-derived human mesenchymal stem cells769783, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38319]], camposKey:0041-1337 2012-01-01 Response to "overenthusiastic interpretations of a nonetheless promising study": Facts and opinions00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=50950]], camposKey:0720-048X 2011-01-01 Clinical and haemodynamic evolution of lesions treated by means of atherectomy with SilverHawk in the femoropopliteal sector543547, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38322]], camposKey:0041-1337 2011-01-01 Intervertebral disc repair by autologous mesenchymal bone marrow cells: A pilot study822828, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47712]], camposKey:0002-8703 2010-01-01 Absence of accelerated atherosclerotic disease progression after intracoronary infusion of bone marrow derived mononuclear cells in patients with acute myocardial infarction-Angiographic and intravascular ultrasound-Results from the TErapia Celular Aplicada al Miocardio Pilot study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69425]], camposKey:1885-5857 2008-06-01 Effect of persistent microvascular obstruction on post-infarction ventricular remodeling following intracoronary bone-marrow cell transplantation: A contrast-enhanced cardiac magnetic resonance study602610, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47810]], camposKey:0300-8932 2008-01-01 Effect of persistent microvascular obstruction on post-infarction ventricular remodeling following intracoronary bone-marrow cell transplantation: A contrast-enhanced cardiac magnetic resonance study Impacto de la obstrucción microvascular persistente en el remodelado ventricular postinfarto tras el implante intracoronario de células mononucleadas de médula ósea: Un estudio de cardiorresonancia602610, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38338]], camposKey:1350-9047 2007-01-01 Cardiac repair by stem cells12581261, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38341]], camposKey:1743-4297 2006-01-01 Experimental models for cardiac regeneration00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69546]], camposKey:1885-5857 2004-03-01 Intracoronary stem cell transplantation in acute myocardial infarction201208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38347]], camposKey:0009-7330 2004-01-01 Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction742748, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47713]], camposKey:0300-8932 2004-01-01 Intracoronary stem cell transplantation in acute myocardial infarction Regeneración miocárdica mediante la implantación intracoronaria de células madre en el infarto agudo de miocardio201208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38220]], camposKey:0021-972X 2004-01-01 Multifunctional cells in human pituitary adenomas: Implications for paradoxical secretion and tumorigenesis45454552, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=14434]], camposKey:0300-8932 2004-01-01 Regeneración miocárdica mediante la implantación intracoronaria de células madre en el infarto agudo de miocardio201208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47714]], camposKey:0041-1345 2003-01-01 Results of percutaneous revascularization in cardiac allograft vascular disease19961998, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38357]], camposKey:0014-2999 1999-01-01 Effects K- and M-opioid receptor agonists on Ca2+ channels in neuroblastoma cells: Involvement of the orphan opioid receptor191198, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38358]], camposKey:0027-8424 1997-01-01 Multi-responsiveness of single anterior pituitary cells to hypothalamic-releasing hormones: A cellular basis for paradoxical secretion1413214137, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6692]], camposKey:0953-816X 1996-01-01 Mechanisms for synchronous calcium oscillations in cultured rat cerebellar neurons192201, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40050]], camposKey:0114-5916 1995-01-01 ACE Inhibitors and Impotence: A Case Series from the Spanish Drug Monitoring System130131, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54395]], camposKey:0020-7292 1995-01-01 Metronidazole during pregnancy323324, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=1075]], camposKey:0197-8462 1994-01-01 Effects of extremely-law-frequency electromagnetic fields on ion transport in several mammalian cells579588, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54397]], camposKey:0213-4233 1994-01-01 Severe neurologic disorders and sialorrhea in an elderly patient treated with ciprofloxacine [ALTERACIONES NEUROLOGICAS GRAVES Y SIALORREA EN UN PACIENTE ANCIANO TRATADO CON CIPROFLOXACINA]450, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47715]], camposKey:0213-005X 1994-01-01 Study of the state of carriers of hemolytic streptococci B in groups A, B, C and G ESTUDIO DEL ESTADO DE PORTADOR DE ESTREPTOCOCOS BETAHEMOLITICOS DE LOS GRUPOS A, B, C Y G285288, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=1061]], camposKey:0264-6021 1993-01-01 Control of Ca2+ entry into HL60 and U937 human leukaemia cells by the filling state of the intracellular Ca2+ stores761766, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=1036]], camposKey:0031-6768 1993-01-01 The pathway for refilling intracellular Ca2+ stores passes through the cytosol in human leukaemia cells465469, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38374]], camposKey:0022-1767 1992-01-01 A monoclonal antibody that detects a specific human neutrophil antigen involved in phorbol myristate acetate- and formyl-methionyl-leucyl- phenylalanine-triggered respiratory burst161168, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=1059]], camposKey:0264-6021 1992-01-01 Agonist-evoked Ca2+ entry in human platelets: a reply343344, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39284]], camposKey:0006-3002 1992-01-01 Effects of the antithrombitic agent PCA 4230 on agonist-induced Ca2+ entry and Ca2+ release in human platelets257260, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=1054]], camposKey:0264-6021 1991-01-01 Agonist-induced Ca2+ influx into human platelets is secondary to the emptying of intracellular Ca2+ stores783789, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38375]], camposKey:0167-4889 1991-01-01 The role of intracellular acidification in calcium mobilization in human neutrophils00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38377]], camposKey:0264-6021 1990-01-01 Arachidonic acid-induced calcium influx in human platelets. Comparison with the effect of thrombin435443, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39283]], camposKey:0950-1991 1990-01-01 Retinoic acid modulation of the early development of the inner ear is associated with the control of c-fos expression10811090, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38379]], camposKey:0005-2736 1989-01-01 Effects of sodium removal on calcium mobilization and dense granule secretion induced by thrombin in human platelets367370, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=1017]], camposKey:0014-2956 1989-01-01 Intracellular Ca2+ potentiates Na+/H+ exchange and cell differentiation induced by phorbol ester in U937 cells709714, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39281]], camposKey:0014-5793 1989-01-01 Leupeptin does not affect the normal signal transduction mechanism in platelets407410, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38378]], camposKey:0006-291X 1989-01-01 Monitoring of the activation of receptor-operated calcium channels in human platelets2429, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38382]], camposKey:0300-5127 1989-01-01 Receptor-operated calcium channels in human platelets980982, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39282]], camposKey:0006-3002 1988-01-01 Thrombin-induced changes of intracellular [Ca2+] and pH in human platelets. Cytoplasmic alkalinization is not a prerequisite for calcium mobilization497500, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40026]], camposKey:0022-3751 1988-01-01 THROMBIN-INDUCED CYTOPLASMIC ALKALINIZATION IN HUMAN-PLATELETS IS NOT A PREREQUISITE FOR CA-MOBILIZATION00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47716]], camposKey:0014-5793 1987-01-01 cAMP reduces the affinity of Ca2+-triggered secretion in platelets183186, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38389]], camposKey:0034-9402 1986-01-01 Ca2+-dependent K+ transport in lymphocytes.459464, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47717]], camposKey:0014-5793 1985-01-01 Ca2+-independent secretion is dependent on cytoplasmic ATP in human platelets283286, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47718]], camposKey:0264-6021 1984-01-01 Effects of prostaglandin I2 and forskolin on the secretion from platelets evoked at basal concentrations of cytoplasmic free calcium by thrombin, collagen, phorbol ester and exogenous diacylglycerol833836, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47719]], camposKey:0264-6021 1984-01-01 Stimulus-response coupling in human platelets. Changes evoked by platelet-activating factor in cytoplasmic free calcium monitored with the fluorescent calcium indicator quin2819827, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47720]], camposKey:0028-0836 1983-01-01 Diacylglycerol and phorbol ester stimulate secretion without raising cytoplasmic free calcium in human platelets317319, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47721]], camposKey:0014-5793 1983-01-01 Trifluoperazine and chlorpromazine block secretion from human platelets evoked at basal cytoplasmic free calcium by activators of C-kinase4346, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47722]], camposKey:0167-4889 1983-01-01 Volume restoration in osmotically swollen lymphocytes does not involve changes in free Ca2+ concentration593596, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38398]], camposKey:0028-0836 1982-01-01 All-or-none response of the Ca2+-dependent K+ channel in inside-out vesicles744746, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47723]], camposKey:0004-0576 1981-01-01 Effect of nomifensine on the oxidative metabolism of rat brain 'in vitro' EFECTO DE LA NOMIFENSINA SOBRE EL METABOLISMO OXIDATIVO DE CEREBRO DE RATA 'IN VITRO'109116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54398]], camposKey:0430-0920 1980-01-01 Effect of clozapine on the oxygen. Glucose uptake and oxidative phosphorylation of rat brain in vitro691697, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38402]], camposKey:0014-5793 1980-01-01 Effects of several inhibitors on the K+ efflux induced by activation of the Ca2+-dependent channel and by valinomycin in the human red cell6568, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47724]], camposKey:0304-8616 1979-01-01 Effect of amphetamine and tyramine on oxidative metabolism of rat brain in vitro EFECTO DE ANFETAMINA Y TIRAMINA SOBRE EL METABOLISMO OXIDATIVO DE CEREBRO DE RATA IN VITRO284286, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47726]], camposKey:0304-8616 1979-01-01 Effect of certain direct-acting sympathicomimetic agents of rat brain in vitro EFECTO DE ALGUNOS FARMACOS SIMPATICOMIMETICOS DE ACCIOU DIRECTA SOBRE EL METABOLISMO OXIDATIVO DE CEREBRO DE RATA IN VITRO287289, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47725]], camposKey:0304-8616 1979-01-01 Effect of clozapine on oxygen consumption, glucose and oxidative phosphorylation of rat brain and liver in vitro EFECTO DE CLOZAPINA SOBRE CONSUMO DE OXIGENO, GLUCOSA Y FOSFORILIZACION OXIDATIVA DE CEREBRO E HIGADO DE RATA IN VITRO290292, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38403]], camposKey:0005-2736 1979-01-01 Stimulation of monovalent cation fluxes by electron donors in the human red cell membrane118130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38404]], camposKey:0005-2736 1978-01-01 Use of salicylic acid to measure the apparent intracellular pH in the ehrlich ascites-tumor cell and Escherichia coli148158, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38407]], camposKey:0005-2736 1977-01-01 Free carboxylate groups required for transport of neutral amino acids by the Ehrlich ascites-tumor cell426428, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38408]], camposKey:0005-2736 1977-01-01 Role of proton dissociation in the transport of acidic amino acids by the Ehrlich ascites tumor cells295312, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38409]], camposKey:0027-8424 1977-01-01 Unexpected additional mode of energization of amino acid transport into Ehrlich cells14881491][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19709]},camposKey: 259 276 Reparación cardíaca con células madre 8493689068Células madre y terapia regenerativa 1 2009-01-01 Real Academia Nacional de Farmacia , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17242]},camposKey: 187 201 Autologous mononuclear bone marrow transplantation for myocardial infarction: The Spanish experience 978-0-387-30939-2Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair: From Basic Research to Clinical Applications 1 2006-01-01 Springer US, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17243]},camposKey: 121 134 Progenitor cells for cardiac regeneration 978-0-387-30939-2Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair: From Basic Research to Clinical Applications 1 2006-01-01 Springer US][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63263]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62692]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56685]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63263]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62692]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56685]]][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145631576]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638426]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145633598]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145633763]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145631529]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145633542]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626851]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626842]]][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62d18a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62d03c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62d139, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62e5fa, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5d3d80, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62e2db, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62e61c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62daa5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62e12c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62d961, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62d3d1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5d3e73, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62d482, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62d29b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5d3e74, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5d3ec7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62d3af, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5d3d7f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5d3e72, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62d54a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62d292, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62d54b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372593, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62df1e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372398, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372150, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62d4de, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@62dadd][][][][][][com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1266]]][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c28], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c27], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c1bb2], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@466ff6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4132af], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4133af], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4130b8], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412fcd], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56f6e0], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413be7], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411f8d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c1b74], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@46087e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41235d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4121f4], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4122e8], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4605ea], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411db0], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4604c6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411ee5], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f3f7], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411bef], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f480], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41255d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4134b9], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413ad8]][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1611a, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1436b, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14366][]
